David Leibowitz, MD
Medical Oncology · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Leibowitz’s office at (650) 321-4121 to ask if they take your plan before you enroll.
California Medical Board record
Licence G84443 · Current
Licensed to practise in California · since 1998 · expires 2027-12-31 · Columbia University College of Physicians and Surgeons.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Hematology
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Medical Oncology
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 43 Part D prescriptions in 2020. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2020 | 43 | 19 | 0% (0) | 51% | $90,727 |
| 2019 | 357 | 80 | None | 50% | $754,483 |
| 2018 | 598 | 109 | None | 36% | $1,289,094 |
| 2017 | 552 | 112 | 3% (16) | 31% | $1,277,017 |
| 2016 | 538 | 100 | 3% (15) | 24% | $1,044,898 |
| 2015 | 474 | 85 | 4% (18) | 30% | $879,072 |
| 2014 | 436 | 74 | 8% (34) | 27% | $563,514 |
| 2013 | 372 | 74 | 5% (18) | 19% | $290,258 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Hydroxyurea | 19 | $1,963 | $103 |
2019: 9 drugs
| Imbruvica | 14 | $235,633 | $16,831 |
| Sprycel | 19 | $214,114 | $11,269 |
| Pegasys | 12 | $51,406 | $4,284 |
| Imatinib Mesylate | 11 | $27,328 | $2,484 |
| Eliquis | 31 | $20,311 | $655 |
| Xarelto | 39 | $17,455 | $448 |
| Pradaxa | 24 | $11,470 | $478 |
| Hydroxyurea | 79 | $5,150 | $65 |
| Anastrozole | 12 | $379 | $32 |
2018: 16 drugs
| Revlimid | 27 | $348,268 | $12,899 |
| Imbruvica | 19 | $316,240 | $16,644 |
| Imatinib Mesylate | 25 | $127,850 | $5,114 |
| Venclexta | 15 | $20,647 | $1,376 |
| Eliquis | 28 | $18,266 | $652 |
| Pradaxa | 29 | $13,997 | $483 |
| Hydroxyurea | 158 | $7,209 | $46 |
| Xarelto | 15 | $6,158 | $411 |
| Anagrelide | 13 | $4,680 | $360 |
| Droxia | 11 | $522 | $47 |
| Dexamethasone | 26 | $339 | $13 |
| Anastrozole | 13 | $233 | $18 |
| Prednisone | 13 | $175 | $13 |
| Prochlorperazine Maleate | 17 | $168 | $10 |
| Allopurinol | 15 | $164 | $11 |
| Lorazepam | 21 | $126 | $6 |
2017: 14 drugs
| Imbruvica | 35 | $411,391 | $11,754 |
| Imatinib Mesylate | 33 | $184,385 | $5,587 |
| Zytiga | 15 | $145,109 | $9,674 |
| Revlimid | 13 | $117,390 | $9,030 |
| Eliquis | 16 | $7,693 | $481 |
| Pradaxa | 16 | $7,477 | $467 |
| Hydroxyurea | 132 | $5,897 | $45 |
| Xarelto | 11 | $4,863 | $442 |
| Anagrelide | 19 | $4,791 | $252 |
| Allopurinol | 19 | $268 | $14 |
| Prednisone | 23 | $194 | $8 |
| Dexamethasone | 11 | $90 | $8 |
| Prochlorperazine Maleate | 12 | $88 | $7 |
| Lorazepam | 32 | $85 | $3 |
2016: 14 drugs
| Imbruvica | 37 | $388,858 | $10,510 |
| Imatinib Mesylate | 34 | $179,928 | $5,292 |
| Zytiga | 12 | $104,984 | $8,749 |
| Gleevec | 11 | $67,958 | $6,178 |
| Hydroxyurea | 150 | $5,301 | $35 |
| Exemestane | 16 | $3,193 | $200 |
| Enoxaparin | 11 | $2,352 | $214 |
| Anagrelide | 12 | $1,199 | $100 |
| Allopurinol | 28 | $403 | $14 |
| Bicalutamide | 16 | $400 | $25 |
| Acyclovir | 15 | $327 | $22 |
| Dexamethasone | 18 | $240 | $13 |
| Prednisone | 20 | $129 | $6 |
| Lorazepam | 14 | $61 | $4 |
2015: 12 drugs
| Imbruvica | 38 | $380,657 | $10,017 |
| Gleevec | 42 | $270,635 | $6,444 |
| Revlimid | 12 | $114,015 | $9,501 |
| Hydroxyurea | 118 | $4,218 | $36 |
| Bicalutamide | 25 | $892 | $36 |
| Anagrelide | 11 | $484 | $44 |
| Megestrol Acetate | 11 | $424 | $39 |
| Gabapentin | 16 | $421 | $26 |
| Acyclovir | 15 | $331 | $22 |
| Allopurinol | 11 | $121 | $11 |
| Omeprazole | 19 | $104 | $5 |
| Dexamethasone | 11 | $62 | $6 |
2014: 16 drugs
| Imbruvica | 26 | $243,270 | $9,357 |
| Gleevec | 32 | $182,513 | $5,704 |
| Zytiga | 12 | $87,282 | $7,273 |
| Hydroxyurea | 78 | $2,685 | $34 |
| Ketoconazole | 11 | $1,243 | $113 |
| Anastrozole | 15 | $521 | $35 |
| Hydrocortisone | 11 | $482 | $44 |
| Gabapentin | 11 | $381 | $35 |
| Hydrocodone-Acetaminophen | 12 | $367 | $31 |
| Anagrelide | 12 | $364 | $30 |
| Acyclovir | 12 | $310 | $26 |
| Lorazepam | 18 | $106 | $6 |
| Omeprazole | 22 | $102 | $5 |
| Dexamethasone | 13 | $85 | $7 |
| Prochlorperazine Maleate | 12 | $77 | $6 |
| Sulfamethoxazole-Trimethoprim | 14 | $64 | $5 |
2013: 8 drugs
| Gleevec | 27 | $156,361 | $5,791 |
| Enoxaparin | 12 | $14,495 | $1,208 |
| Hydroxyurea | 91 | $4,737 | $52 |
| Bicalutamide | 13 | $1,856 | $143 |
| Anastrozole | 15 | $883 | $59 |
| Gabapentin | 14 | $384 | $27 |
| Omeprazole | 19 | $270 | $14 |
| Lorazepam | 14 | $79 | $6 |
Money from drug and device companies
$24 in 2019
A payment is not proof that care is biased.
| Seattle Genetics | Adcetris | $12 | 1 payment
|
| Pfizer | Ibrance | $12 | 1 payment
|
See all 2 published payments
| Pfizer | Education · 2019-03-27 | Ibrance | $12 |
| Seattle Genetics | Education · 2019-03-13 | Adcetris | $12 |
Professional record
- NPI
- 1508975665
- Licence
- CA G84443California G84443: Current · expires 2027-12-31
More record details
- Sole proprietor
- No
- Taxonomy
- Medical oncology (207RX0202X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-08-30
- NPI last updated
- 2012-01-20
This is when the NPI record was last certified, not a medical board exam.